September
Fisher Clinical Services, Inc. (PDF) (September 12, 2025)
Fresenius Kabi USA, LLC (PDF) (September 12, 2025)
Cambridge Isotope Laboratories, Inc. (PDF) (September 12, 2025)
Cambridge Isotope Laboratories, Inc. (PDF) (September 12, 2025)
Catalent Pharma Solutions, LLC (PDF) (September 12, 2025)
Chanelle D. Remien, DVM; Decision and Order (PDF) (September 11, 2025)
Biopharmaceutical Research Company (PDF) (September 11, 2025)
30-Day Notice (Extension): Application for Registration—DEA Form 363, Application for Registration Renewal—DEA Form 363a (PDF) (September 10, 2025)
30-Day Notice (Extension): Annual Reporting for Manufacturers of Listed Chemicals (PDF) (September 10, 2025)
60-Day Notice: Reporting and Recordkeeping for Digital Certificates—Form 251 (PDF) (September 9, 2025)
VA Cooperative Studies Program (PDF) (September 8, 2025)
60-Day Notice (Extension): Report of Mail Order Transactions (PDF) (September 5, 2025)
August
Cambrex Charles City (PDF) (August 21, 2025)
Continuus Pharmaceuticals (PDF) (August 21, 2025)
Cambrex High Point, Inc. (PDF) (August 21, 2025)
Vici Health Sciences, LLC (PDF) (August 21, 2025)
Cambrex High Point, Inc. (PDF) (August 21, 2025)
Catalent CTS, LLC (PDF) (August 21, 2025)
Kenneth Pherson, D.O.; Decision and Order (PDF) (August 20, 2025)
Andrew Konen, M.D.; Decision and Order (PDF) (August 20, 2025)
Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I (PDF) (August 15, 2025)
Benuvia Operations, LLC (PDF) (August 12, 2025)
Benuvia Operations, LLC (PDF) (August 11, 2025)
Veterans Pharmaceuticals, Inc. (PDF) (August 11, 2025)
Experic LLC (PDF) (August 11, 2025)
Cambrex Charles City (PDF) (August 11, 2025)
Curia New York Inc. (PDF) (August 11, 2025)
Chattem Chemicals (PDF) (August 11, 2025)
Galephar Pharmaceutical Research Inc. (PDF) (August 11, 2025)
Chattem Chemicals (PDF) (August 11, 2025)
Biopharmaceutical Research Company (PDF) (August 11, 2025)
Final Rule: Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (PDF) (August 8, 2025)
Chemtos, LLC (PDF) (August 8, 2025)
July
Taha Dias, M.D.; Decision and Order (PDF) (July 25, 2025)
Thomas Draschil, M.D.; Decision and Order (PDF) (July 22, 2025)
AndersonBrecon, Inc. DBA PCI Pharma Services (PDF) (July 17, 2025)
AMPAC Fine Chemicals LLC (PDF) (July 17, 2025)
Curia Missouri Inc. (PDF) (July 17, 2025)
Curia New York, Inc. (PDF) (July 17, 2025)
Cerilliant Corporation (PDF) (July 17, 2025)
Cerilliant Corporation (PDF) (July 17, 2025)
Benson Sergiles, P.A.; Decision and Order (PDF) (July 16, 2025)
Sasha Melissa Ikramelahai; Decision and Order (PDF) (July 16, 2025)
Osric Malone Prioleau, N.P.; Decision And Order (PDF) (July 16, 2025)
Diana Clouthier, N.P.; Decision and Order (PDF) (July 16, 2025)
Elias Garcia Garcia, P.A.; Decision and Order (PDF) (July 14, 2025)
JYA LLC d/b/a Webb's Square Pharmacy; Decision and Order (PDF) (July 14, 2025)
Michael Bouknight; Decision and Order (PDF) (July 14, 2025)
Just Here II Pharmacy; Decision and Order (PDF) (July 14, 2025)
John Hanley, P.A.; Decision and Order (PDF) (July 9, 2025)
Andrew Jones, M.D.; Decision and Order (PDF) (July 9, 2025)
Hayriye Gok, M.D.; Decision and Order (PDF) (July 9, 2025)
William Washington, M.D.; Decision and Order (PDF) (July 8, 2025)
Tanya Newlove, N.P.; Decision and Order (PDF) (July 8, 2025)
Mark Agresti, M.D.; Decision and Order (PDF) (July 8, 2025)
Loretta Clement, M.D.; Decision and Order (PDF) (July 7, 2025)
Exempt Chemical Preparations Under the Controlled Substances Act (PDF) (July 1, 2025)
June
Notice of Intent: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I (PDF) (June 26, 2025)
Scott Hansen, A.R.N.P.; Default Decision and Order (PDF) (June 26, 2025)
Bohdan Olesnicky, M.D.; Decision and Order (PDF) (June 26, 2025)
Arizona Department of Corrections (PDF) (June 24, 2025)
William Thompson IV, M.D.; Decision and Order (PDF) (June 23, 2025)
New Scam Letters and Calls Target Medical Practitioners (PDF) (June 23, 2025)
AndersonBrecon, Inc. DBA PCI Pharma Services (PDF) (June 18, 2025)
Veranova, L.P. (PDF) (June 18, 2025)
Veranova, L.P. (PDF) (June 18, 2025)
AJNA Biosciences (PDF) (June 18, 2025)
American Radiolabeled Chem (PDF) (June 18, 2025)
James F. Brown, D.P.M.; Default Decision and Order (PDF) (June 13, 2025)
Proposed Rule: Placement of Three Specific Fentanyl-Related Substances in Schedule I (PDF) (June 10, 2025)
Proposed Rule: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl) cyclohexyl]piperidine) in Schedule I (PDF) (June 10, 2025)
Harry Kram, M.D.; Decision and Order (PDF) (June 10, 2025)
Serge Menkin, M.D.; Decision and Order (PDF) (June 10, 2025)
Ron Dunchok, M.D.; Decision and Order (PDF) (June 9, 2025)
Lee S. Altman, M.D.; Decision and Order (PDF) (June 5, 2025)
Usona Institute, Inc. (PDF) (June 5, 2025)
ANI Pharmaceuticals Inc. (PDF) (June 5, 2025)
Proposed Rule: Designation of Propionyl Chloride as a List I Chemical (PDF) (June 3, 2025)
Proposed Rule: Placement of 4-Fluoroamphetamine in Schedule I (PDF) (June 3, 2025)
Correction: Placement of 2-Methyl AP-237 in Schedule I (PDF) (June 3, 2025)
Veranova, L.P. (PDF) (June 2, 2025)
ANI Pharmaceuticals Inc. (PDF) (June 2, 2025)
May
Khursheed Haider, M.D.; Decision and Order (PDF) (May 22, 2025)
Quagen Pharmaceuticals LLC (PDF) (May 20, 2025)
Patheon API Inc. (PDF) (May 20, 2025)
Usona Institute (PDF) (May 20, 2025)
Wedgewood Pharmacy LLC (PDF) (May 14, 2025)
Research Triangle Institute (PDF) (May 14, 2025)
Pall Life Sciences PR, LLC (PDF) (May 14, 2025)
Edmund Ayoub Jr., M.D.; Decision and Order (PDF) (May 7, 2025)
Margaret Dennis, D.M.D.; Default Decision and Order (PDF) (May 7, 2025)
Peter Dashkoff, M.D.; Decision and Order (PDF) (May 7, 2025)
Mohan Kaza, M.D.; Default Decision and Order (PDF) (May 7, 2025)
Unither Manufacturing LLC (PDF) (May 1, 2025)
United States Pharmacopeial Convention (PDF) (May 1, 2025)
April
Skalar Pharma LLC (PDF) (April 28, 2025)
Lipomed (PDF) (April 28, 2025)
Pisgah Laboratories Inc. (PDF) (April 28, 2025)
Almac Clinical Services Inc. (ASCI) (PDF) (April 28, 2025)
VHG Labs DBA LGC Standards (PDF) (April 28, 2025)
Pharmaron Manufacturing Services (US), LLC; Correction (PDF) (April 28, 2025)
Siemens Healthcare Diagnostics Inc. (PDF) (April 28, 2025)
Liberty Pharmacy Inc.; Metro Care Pharmacy Inc.; Ritecare Pharmacy Inc.; United Pharmacy Upper Darby Inc.; Decision and Order (PDF) (April 25, 2025)
Syed Warsi, M.D.; Decision and Order (PDF) (April 25, 2025)
Royal Emerald Pharmaceuticals (PDF) (April 25, 2025)
SpecGx LLC (PDF) (April 25, 2025)
De Novo Services, LLC; Decision and Order (PDF) (April 23, 2025)
Svetlana Burtman, N.P.; Decision and Order (PDF) (April 22, 2025)
John Stanton, M.D.; Decision and Order (PDF) (April 21, 2025)
Scottsdale Research Institute (PDF) (April 18, 2025)
Patheon API Services Inc. (PDF) (April 18, 2025)
Myonex LLC (PDF) (April 18, 2025)
Stepan Company (PDF) (April 18, 2025)
Research Triangle Institute (PDF) (April 18, 2025)
Restek Corporation (PDF) (April 18, 2025)
Henry-Norbert O. Ndekwe, M.D.; Decision and Order (PDF) (April 16, 2025)
Moustafa M. Aboshady, M.D.; Decision and Order (PDF) (April 16, 2025)
Empire Pharmacy Inc.; Skyline Pharmacy Inc.; Decision and Order (PDF) (April 16, 2025)
Ajumobi Agu, M.D.; Decision and Order (PDF) (April 16, 2025)
Lona Bibbs-Walker, D.D.S.; Decision and Order (PDF) (April 16, 2025)
Victor Augusto Silva, M.D.; Order (PDF) (April 16, 2025)
David Israel, M.D.; Decision and Order (PDF) (April 16, 2025)
Phong H. Tran, M.D.; Decision and Order (PDF) (April 14, 2025)
Eagle Pharmacy; Decision and Order (PDF) (April 14, 2025)
Mariste Pharmacy; Decision and Order (PDF) (April 14, 2025)
Prescript Pharmaceuticals; Decision and Order (PDF) (April 2, 2025)
Jennifer Marie Lager-Fermon, D.O.; Decision and Order (PDF) (April 2, 2025)
Phong H. Tran, M.D.; Decision and Order (PDF) (April 1, 2025)
Baijes Bissonnet Pharmacy; Decision and Order (PDF) (April 1, 2025)
Mary Massullo, D.O.; Decision and Order (PDF) (April 1, 2025)
- REGISTRATION
- REPORTING
- RESOURCES
- CONTACT US
- PRIVACY NOTICE
- GET EMAIL UPDATES
Get Email Updates
The United States Department of Justice
You are now leaving a Department of Justice Web site.
You are about to access:
The Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.
Thank you for visiting our site.